Clinical Trial: ORKA-002-211 A Phase I Study to Evaluate ORKA-002 in Healthy Volunteers Following A Single Dose

U.S., April 26 -- ClinicalTrials.gov registry received information related to the study (NCT06944379) titled 'ORKA-002-211 A Phase I Study to Evaluate ORKA-002 in Healthy Volunteers Following A Single Dose' on April 15.

Brief Summary: This is a Phase 1, first-in-human study to evaluate the safety, tolerability, and pharmacokinetics of ORKA-002 in healthy participants.

Study Start Date: July, 2025

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: DRUG: ORKA-002

ORKA-002 is supplied as sterile solution to be administered by SC injection

OTHER: Placebo

Placebo solution to be administered at a matching volume by SC injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Oruka Therapeutics, Inc.

Published by H...